The findings indicate that neuroprotective drug treatments did not reverse these RAAS alterations.
Genes · 9 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The findings indicate that neuroprotective drug treatments did not reverse these RAAS alterations.
Key results showed significant downregulation of *Agtr2* and *Bdkrb1* expression in the hippocampi of vehicle-treated WS rats compared to wild-type, along with decreased *Agtr1a* and *Agtr1b*. Treatment-naïve WS rats exhibited decreased hippocampal *Ace*, *Ace2*, and *Mas1* expression. Critically, none of the administered drug treatments rescued the RAAS gene downregulation observed in the vehicle-treated WS group. Limitations include the transcriptomic-level analysis only and the use of aged rats with established neurological symptoms.